Pixels & Pills

Entries Tagged as 'Opinion'

POINT/COUNTERPOINT: Should You “Cross Streams” When You’re A Social Media Professional?

January 11th, 2012 · 1 Comment · Opinion

This post is part of a series of point/counterpoint arguments proposed by different members of the Pixels & Pills staff. We’re strong believers that healthy arguments can yield the best solutions, and we hope that you enjoy our series. Feel free to add your own arguments in the comments section below!
by Krissy Goelz (@krisgoelz)
In The [...]

Share

[Read more →]

Tags:··········

POINT/COUNTERPOINT: Should You “Cross Streams” When You’re A Social Media Professional?

January 10th, 2012 · No Comments · Opinion

This post is part of a series of point/counterpoint arguments proposed by different members of the Pixels & Pills staff. We’re strong believers that healthy arguments can yield the best solutions, and we hope that you enjoy our series. Feel free to add your own arguments in the comments section below!
by Jason Brandt (@jasondmg3)
As Egon [...]

Share

[Read more →]

Tags:··········

Little Comments, Big Privacy

May 11th, 2011 · No Comments · Opinion

(via Chuck and Beans)
By Jason Brandt (@JasonDMG3)
“Great story. Loved the last part; very moving.”
“I disagree completely – this is what’s wrong with America today!”
While adding a comment to a blog post or a news article may seem trivial, it’s part of a larger and very important story.
Interactivity – the idea that you can offer your [...]

Share

[Read more →]

Tags:······················

Why the Core Visual Aid is DEAD…Vive la IVA!

May 10th, 2010 · No Comments · Opinion

By Paul Harrington
R.I.P., CVA.
Friends, Romans, and countrymen, lend me your ears: I come not to praise the CVA, but to bury it.
The CVA – or Core Visual Aid – the most commonly used sales tool in the armamentarium of pharmaceutical sales is dead, dead, dead. Certainly, for decades it had served us well: it gave [...]

Share

[Read more →]

Tags:··········

Following Up with Amy Cowan of Google

April 12th, 2010 · 3 Comments · Opinion

We’ll be kicking off this week’s theme of “Ones to Watch” by revisiting Pixels & Pills’ interview with Google’s Amy Cowan at the ePharma Summit earlier this year.

By Jason Brandt
Last month, Pixels & Pills’ Carl Turner interviewed Amy Cowan, head of the health industry for Google at the ePharma Summit.
In her conversation with Carl, Amy [...]

Share

[Read more →]

Tags:·······

More to Follow: Pixels & Pills’ Favorite Pharma Folks, Part II

April 5th, 2010 · 12 Comments · Knowledge

By Kimberly Reyes (@CommDuCoeur)
Last August, Pixels and Pills provided you with a handy “who’s who” list of 10 Pharma Twitterers that we can’t get enough of.
We’re calling this year “the year that everything changes” for Pharma, and with new challenges come new faces.  We’ve since added some names to the list and are proud to [...]

Share

[Read more →]

Tags:···············

Like Talking to a Wall: Why Pharma Needs to Speak Up

March 11th, 2010 · 2 Comments · News, Opinion

From Mark McCoy
There is a high level of dissatisfaction with our healthcare system these days, which makes pharma companies vulnerable to becoming a target for blame.  It’s hard to believe that even though pharma companies discover and develop the drugs that advance medical treatment, the industry is so vilified that only cigarette makers and big [...]

Share

[Read more →]

Tags:·······

Matthew Whalen of Impact at the FDA Hearings

November 12th, 2009 · No Comments · News

Matthew Whalen of Impact was kind enough to give us his take on the FDA Hearings on Social Media.

Share

[Read more →]

Tags:·············

Do We Need FDA Hearings on SEO & User Experience?

November 11th, 2009 · No Comments · News, Opinion

By Sven Larsen (@zemoga)
How much attention should the government be paying to social media? As the Pixels and Pills team gears up for their coverage of the FDA hearings on social media, I’ve been thinking a lot about how patients receive their information from the web. And I wonder if the FDA shouldn’t be looking [...]

Share

[Read more →]

Tags:············